Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Average Rating of “Hold” from Brokerages

Phibro Animal Health Corporation (NASDAQ:PAHC) has been assigned a consensus recommendation of “Hold” from the six research firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $37.50.

A number of analysts recently commented on the stock. Morgan Stanley set a $49.00 price target on shares of Phibro Animal Health in a research note on Friday, February 6th. Zacks Research cut shares of Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a report on Monday, February 9th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Phibro Animal Health in a report on Monday, December 29th. Finally, JPMorgan Chase & Co. lifted their price target on Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a research report on Friday, November 7th.

Insider Activity

In related news, CEO Jack Bendheim sold 7,040 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $51.42, for a total transaction of $361,996.80. Following the completion of the transaction, the chief executive officer owned 22,600 shares of the company’s stock, valued at approximately $1,162,092. The trade was a 23.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold 288,640 shares of company stock valued at $13,653,329 over the last quarter. Corporate insiders own 50.13% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Penserra Capital Management LLC purchased a new position in Phibro Animal Health during the third quarter worth about $519,000. Capricorn Fund Managers Ltd bought a new stake in shares of Phibro Animal Health during the 3rd quarter valued at about $10,233,000. Allspring Global Investments Holdings LLC purchased a new position in shares of Phibro Animal Health during the third quarter worth about $8,931,000. Bailard Inc. purchased a new position in shares of Phibro Animal Health during the second quarter worth about $259,000. Finally, Squarepoint Ops LLC bought a new position in shares of Phibro Animal Health in the second quarter worth approximately $813,000. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Stock Up 3.2%

Shares of NASDAQ PAHC opened at $53.10 on Friday. Phibro Animal Health has a one year low of $16.16 and a one year high of $56.30. The company has a debt-to-equity ratio of 2.14, a current ratio of 3.05 and a quick ratio of 1.22. The business’s fifty day moving average price is $43.13 and its 200-day moving average price is $40.57. The stock has a market capitalization of $2.15 billion, a PE ratio of 23.60, a P/E/G ratio of 0.79 and a beta of 0.80.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.18. The company had revenue of $373.91 million during the quarter, compared to analyst estimates of $355.64 million. Phibro Animal Health had a return on equity of 38.28% and a net margin of 6.29%.Phibro Animal Health has set its FY 2026 guidance at 2.930-3.100 EPS. On average, equities research analysts anticipate that Phibro Animal Health will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 25th. Shareholders of record on Wednesday, March 4th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Wednesday, March 4th. Phibro Animal Health’s payout ratio is presently 21.33%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.